tiprankstipranks
Advertisement
Advertisement

PGEN Stock Latest News

Precigen presents long-term follow-up data from study of Papzimeos
The FlyPrecigen presents long-term follow-up data from study of Papzimeos
3d ago
PGEN
Precigen price target raised to $14 from $11 at H.C. Wainwright
PremiumThe Fly
Precigen price target raised to $14 from $11 at H.C. Wainwright
7d ago
PGEN
Precigen receives orphan drug exclusivity for papzimeos in the U.S.
PremiumThe Fly
Precigen receives orphan drug exclusivity for papzimeos in the U.S.
8d ago
PGEN
Precigen’s PAPZIMEOS Launch Drives Surging Q1 Revenue
PremiumCompany Announcements
Precigen’s PAPZIMEOS Launch Drives Surging Q1 Revenue
15d ago
PGEN
Precigen Earnings Call Highlights PAPZIMEOS Launch Surge
PremiumCompany Announcements
Precigen Earnings Call Highlights PAPZIMEOS Launch Surge
20d ago
PGEN
Precigen price target raised to $11 from $10 at H.C. Wainwright
PremiumThe FlyPrecigen price target raised to $11 from $10 at H.C. Wainwright
21d ago
PGEN
Precigen price target raised to $11 from $9 at Citizens
Premium
The Fly
Precigen price target raised to $11 from $9 at Citizens
21d ago
PGEN
Precigen reports Q1 EPS (2c) vs. (18c) last year
Premium
The Fly
Precigen reports Q1 EPS (2c) vs. (18c) last year
21d ago
PGEN
Precigen, Inc. (PGEN) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Precigen, Inc. (PGEN) Q1 Earnings Cheat Sheet
26d ago
PGEN
Midday Fly By: Health insurers get ‘positive surprise’ from CMS
PremiumThe Fly
Midday Fly By: Health insurers get ‘positive surprise’ from CMS
2M ago
CI
EL
Morning Movers: Broadcom gains following pact to supply custom TPUs for Google
PremiumThe Fly
Morning Movers: Broadcom gains following pact to supply custom TPUs for Google
2M ago
EL
CVS
Precigen sees Q1 revenue exceeding $18M, consensus $20.8M
PremiumThe Fly
Precigen sees Q1 revenue exceeding $18M, consensus $20.8M
2M ago
PGEN
Precigen sees ‘robust uptake’ in usage of Papzimeos since its launch
PremiumThe FlyPrecigen sees ‘robust uptake’ in usage of Papzimeos since its launch
2M ago
PGEN
Papzimeos: Accelerating Commercial Ramp, Larger-Than-Expected RRP Market, and Strong 2026 Revenue Outlook Support Buy Rating
Premium
Ratings
Papzimeos: Accelerating Commercial Ramp, Larger-Than-Expected RRP Market, and Strong 2026 Revenue Outlook Support Buy Rating
2M ago
PGEN
Precigen Earnings Call Signals Powerful Launch Momentum
Premium
Company Announcements
Precigen Earnings Call Signals Powerful Launch Momentum
2M ago
PGEN
Precigen jumps on Q1 outlook despite earnings miss
PremiumThe Fly
Precigen jumps on Q1 outlook despite earnings miss
2M ago
PGEN
Buy Rating on Papzimeos Driven by Strong Early Launch Traction, Multi‑Year Growth Catalysts, and Long-Term IP Protection
PremiumRatings
Buy Rating on Papzimeos Driven by Strong Early Launch Traction, Multi‑Year Growth Catalysts, and Long-Term IP Protection
2M ago
PGEN
Precigen price target raised to $10 from $9 at H.C. Wainwright
PremiumThe Fly
Precigen price target raised to $10 from $9 at H.C. Wainwright
2M ago
PGEN
Precigen price target raised to $9 from $8 at Citizens
PremiumThe Fly
Precigen price target raised to $9 from $8 at Citizens
2M ago
PGEN
Options Volatility and Implied Earnings Moves Today, March 25, 2026
PremiumMarket NewsOptions Volatility and Implied Earnings Moves Today, March 25, 2026
2M ago
KC
JEF
Options Volatility and Implied Earnings Moves This Week, March 23 – March 27, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves This Week, March 23 – March 27, 2026
2M ago
AIR
CCL
Is PGEN a Buy, Before Earnings?
Premium
Pre-Earnings
Is PGEN a Buy, Before Earnings?
3M ago
PGEN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >